The clinical research landscape is changing and clinical trials are evolving to find new, faster and more efficient ways to bring new treatments to patients.
The UK Life Sciences Industrial Strategy and the Life Sciences Sector Deal 2 set out the Government’s commitment to consolidate the UK as a world-leader in delivering clinical trials using novel or complex designs and/or innovative approaches to research delivery. These have come to be known as CIDs (Complex Innovative Design studies).
The COVID19 pandemic is accelerating uptake and acceptance of this new era of clinical trials. This virtual event will generate discussion on where we were, where we are now, how we got there and where we go next.
More information